Identification and validation of molecular subtypes and prognostic models in patients with kidney cancer based on differential genes based on B cells: a multiomics analysis

基于B细胞差异基因的肾癌患者分子亚型及预后模型鉴定与验证:一项多组学分析

阅读:2

Abstract

BACKGROUND: B cells play a variety of complex roles in cancer, both promoting cancer progression and enhancing anti-tumor immune responses, but their mechanism of action in kidney cancer has not been elucidated. RESULTS: We collected kidney cancer sample data from the GEO database and TCGA database, mapped the single-cell landscape inside kidney cancer tissue, identified 25 B-cell-related genes, and based on this, identified related molecular subtypes of kidney cancer patients, and explored their internal microenvironment characteristics. Finally, we constructed a 6-gene biological prognostic model that can be used to predict survival in patients with renal cancer, and we further validated the predictive performance of the model based on imaging omics. It is worth mentioning that the structural patterns and functional sites of 6 model gene transcription proteins were also mined. CONCLUSIONS: Overall, we explored for the first time the profound role of B cells in kidney cancer and developed a bio-predictive model based on B cell-related genes, providing scientific guidance for personalized treatment of kidney cancer patients.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。